Peripheral blood stem cell collection and transplantation in paediatric malignancies

A monocentric experience

M. G. Petris, G. De Silvestro, S. Cesaro, C. Messina, P. Marson, R. Destro, M. V. Gazzola, L. Masiero, M. Carli, S. Varotto, E. Calore, G. Scarzello, L. Zanesco

Research output: Contribution to journalArticle

Abstract

Thirty-seven patients underwent peripheral blood stem cell (PBSC) collection from May 1994 to May 1997. Twenty-five were males and 12 were females, the median age at collection was 11.5 years (range 1-27.4) and the median weight was 38 kg (range 9-80). As mobilising chemotherapy, cyclophosphamide, etoposide, doxorubicin and cytosine arabinoside were the drugs most frequently used in association with G-CSF for a total of 47 courses. Sixty-one aphereses were performed with a median collection of CD34+ and cells/kg of 3.6 x 106 (range 0.6-31.8) and (range 0.1-1260), respectively. Minimal residual disease (MRD) was found in five of the 30 investigated aphereses. Twenty-one of the 37 patients underwent high-dose chemotherapy with autologous stem cell rescue: in seven the stem cell source was peripheral blood and bone marrow. The median duration of hospitalization was 18 days for the PBSC group and 23 days for the PBSC/ABMT group. Overall survival was 78.7% at a median follow-up of 18 months (range 2-31) and the DFS was 52% without difference depending on stem cell source. Compared to a historical group of ABMT patients, the PBSC group showed a statistical advantage in terms of neutrophils and platelet engraftment, blood and platelet requirements, and length of hospitalization. PBSC collection is a feasible procedure also in the paediatric setting providing that vascular access is adequate. As already reported, PBSC transplant results in faster engraftment and shorter hospitalization that could allow a better utilization of health financial resources. The question whether the source of stem cells could influence transplant outcome would require a prospective randomised study.

Original languageEnglish
JournalBone Marrow Transplantation
Volume21
Issue numberSUPPL. 5
Publication statusPublished - 1997

Fingerprint

Peripheral Blood Stem Cell Transplantation
Pediatrics
Stem Cells
Neoplasms
Blood Component Removal
Hospitalization
Blood Platelets
Transplants
Drug Therapy
Health Resources
Cytarabine
Residual Neoplasm
Granulocyte Colony-Stimulating Factor
Etoposide
Doxorubicin
Cyclophosphamide
Blood Vessels
Peripheral Blood Stem Cells
Neutrophils
Bone Marrow

Keywords

  • Paediatric malignancy
  • Peripheral blood stem cell collection
  • Peripheral blood stem cell transplant
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Petris, M. G., De Silvestro, G., Cesaro, S., Messina, C., Marson, P., Destro, R., ... Zanesco, L. (1997). Peripheral blood stem cell collection and transplantation in paediatric malignancies: A monocentric experience. Bone Marrow Transplantation, 21(SUPPL. 5).

Peripheral blood stem cell collection and transplantation in paediatric malignancies : A monocentric experience. / Petris, M. G.; De Silvestro, G.; Cesaro, S.; Messina, C.; Marson, P.; Destro, R.; Gazzola, M. V.; Masiero, L.; Carli, M.; Varotto, S.; Calore, E.; Scarzello, G.; Zanesco, L.

In: Bone Marrow Transplantation, Vol. 21, No. SUPPL. 5, 1997.

Research output: Contribution to journalArticle

Petris, MG, De Silvestro, G, Cesaro, S, Messina, C, Marson, P, Destro, R, Gazzola, MV, Masiero, L, Carli, M, Varotto, S, Calore, E, Scarzello, G & Zanesco, L 1997, 'Peripheral blood stem cell collection and transplantation in paediatric malignancies: A monocentric experience', Bone Marrow Transplantation, vol. 21, no. SUPPL. 5.
Petris MG, De Silvestro G, Cesaro S, Messina C, Marson P, Destro R et al. Peripheral blood stem cell collection and transplantation in paediatric malignancies: A monocentric experience. Bone Marrow Transplantation. 1997;21(SUPPL. 5).
Petris, M. G. ; De Silvestro, G. ; Cesaro, S. ; Messina, C. ; Marson, P. ; Destro, R. ; Gazzola, M. V. ; Masiero, L. ; Carli, M. ; Varotto, S. ; Calore, E. ; Scarzello, G. ; Zanesco, L. / Peripheral blood stem cell collection and transplantation in paediatric malignancies : A monocentric experience. In: Bone Marrow Transplantation. 1997 ; Vol. 21, No. SUPPL. 5.
@article{09c6e8ac6b60429381f565d0b67c4796,
title = "Peripheral blood stem cell collection and transplantation in paediatric malignancies: A monocentric experience",
abstract = "Thirty-seven patients underwent peripheral blood stem cell (PBSC) collection from May 1994 to May 1997. Twenty-five were males and 12 were females, the median age at collection was 11.5 years (range 1-27.4) and the median weight was 38 kg (range 9-80). As mobilising chemotherapy, cyclophosphamide, etoposide, doxorubicin and cytosine arabinoside were the drugs most frequently used in association with G-CSF for a total of 47 courses. Sixty-one aphereses were performed with a median collection of CD34+ and cells/kg of 3.6 x 106 (range 0.6-31.8) and (range 0.1-1260), respectively. Minimal residual disease (MRD) was found in five of the 30 investigated aphereses. Twenty-one of the 37 patients underwent high-dose chemotherapy with autologous stem cell rescue: in seven the stem cell source was peripheral blood and bone marrow. The median duration of hospitalization was 18 days for the PBSC group and 23 days for the PBSC/ABMT group. Overall survival was 78.7{\%} at a median follow-up of 18 months (range 2-31) and the DFS was 52{\%} without difference depending on stem cell source. Compared to a historical group of ABMT patients, the PBSC group showed a statistical advantage in terms of neutrophils and platelet engraftment, blood and platelet requirements, and length of hospitalization. PBSC collection is a feasible procedure also in the paediatric setting providing that vascular access is adequate. As already reported, PBSC transplant results in faster engraftment and shorter hospitalization that could allow a better utilization of health financial resources. The question whether the source of stem cells could influence transplant outcome would require a prospective randomised study.",
keywords = "Paediatric malignancy, Peripheral blood stem cell collection, Peripheral blood stem cell transplant, Treatment",
author = "Petris, {M. G.} and {De Silvestro}, G. and S. Cesaro and C. Messina and P. Marson and R. Destro and Gazzola, {M. V.} and L. Masiero and M. Carli and S. Varotto and E. Calore and G. Scarzello and L. Zanesco",
year = "1997",
language = "English",
volume = "21",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Peripheral blood stem cell collection and transplantation in paediatric malignancies

T2 - A monocentric experience

AU - Petris, M. G.

AU - De Silvestro, G.

AU - Cesaro, S.

AU - Messina, C.

AU - Marson, P.

AU - Destro, R.

AU - Gazzola, M. V.

AU - Masiero, L.

AU - Carli, M.

AU - Varotto, S.

AU - Calore, E.

AU - Scarzello, G.

AU - Zanesco, L.

PY - 1997

Y1 - 1997

N2 - Thirty-seven patients underwent peripheral blood stem cell (PBSC) collection from May 1994 to May 1997. Twenty-five were males and 12 were females, the median age at collection was 11.5 years (range 1-27.4) and the median weight was 38 kg (range 9-80). As mobilising chemotherapy, cyclophosphamide, etoposide, doxorubicin and cytosine arabinoside were the drugs most frequently used in association with G-CSF for a total of 47 courses. Sixty-one aphereses were performed with a median collection of CD34+ and cells/kg of 3.6 x 106 (range 0.6-31.8) and (range 0.1-1260), respectively. Minimal residual disease (MRD) was found in five of the 30 investigated aphereses. Twenty-one of the 37 patients underwent high-dose chemotherapy with autologous stem cell rescue: in seven the stem cell source was peripheral blood and bone marrow. The median duration of hospitalization was 18 days for the PBSC group and 23 days for the PBSC/ABMT group. Overall survival was 78.7% at a median follow-up of 18 months (range 2-31) and the DFS was 52% without difference depending on stem cell source. Compared to a historical group of ABMT patients, the PBSC group showed a statistical advantage in terms of neutrophils and platelet engraftment, blood and platelet requirements, and length of hospitalization. PBSC collection is a feasible procedure also in the paediatric setting providing that vascular access is adequate. As already reported, PBSC transplant results in faster engraftment and shorter hospitalization that could allow a better utilization of health financial resources. The question whether the source of stem cells could influence transplant outcome would require a prospective randomised study.

AB - Thirty-seven patients underwent peripheral blood stem cell (PBSC) collection from May 1994 to May 1997. Twenty-five were males and 12 were females, the median age at collection was 11.5 years (range 1-27.4) and the median weight was 38 kg (range 9-80). As mobilising chemotherapy, cyclophosphamide, etoposide, doxorubicin and cytosine arabinoside were the drugs most frequently used in association with G-CSF for a total of 47 courses. Sixty-one aphereses were performed with a median collection of CD34+ and cells/kg of 3.6 x 106 (range 0.6-31.8) and (range 0.1-1260), respectively. Minimal residual disease (MRD) was found in five of the 30 investigated aphereses. Twenty-one of the 37 patients underwent high-dose chemotherapy with autologous stem cell rescue: in seven the stem cell source was peripheral blood and bone marrow. The median duration of hospitalization was 18 days for the PBSC group and 23 days for the PBSC/ABMT group. Overall survival was 78.7% at a median follow-up of 18 months (range 2-31) and the DFS was 52% without difference depending on stem cell source. Compared to a historical group of ABMT patients, the PBSC group showed a statistical advantage in terms of neutrophils and platelet engraftment, blood and platelet requirements, and length of hospitalization. PBSC collection is a feasible procedure also in the paediatric setting providing that vascular access is adequate. As already reported, PBSC transplant results in faster engraftment and shorter hospitalization that could allow a better utilization of health financial resources. The question whether the source of stem cells could influence transplant outcome would require a prospective randomised study.

KW - Paediatric malignancy

KW - Peripheral blood stem cell collection

KW - Peripheral blood stem cell transplant

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0031543801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031543801&partnerID=8YFLogxK

M3 - Article

VL - 21

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 5

ER -